Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1920 in Healthy Participants

NCT05751642 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

BIOLOGICAL: ALXN1920
BIOLOGICAL: Placebo
BIOLOGICAL: ALXN1920
BIOLOGICAL: ALXN1920

Sponsor

Alexion Pharmaceuticals, Inc.